Importantly, these transformed cells also displayed sensitivity to BCL-2 inhibition, a vulnerability characteristic of classical SCLC biology and one that has motivated interest in anti-apoptotic targeting strategies in transformed disease. This evidence concerns the gene BCL2 and small cell lung carcinoma.